To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Big exit for Enterprise Investors
The firm has sold a 69 per cent stake in Polish pharmaceutical group Polfa Kutno for $79m, yielding a 5.4 multiple on the invested capital.
